Keyphrases
Schizophrenia
100%
Alzheimer's Disease
90%
Dementia
20%
Schizophrenic Patients
18%
Gene Expression
18%
Neuropathology
17%
Brain Regions
16%
Patients with Schizophrenia
16%
Oligodendrocyte
15%
Alzheimer's Disease Pathology
13%
Dorsolateral Prefrontal Cortex (DLPFC)
12%
Prefrontal Cortex
12%
Neurofibrillary Tangles
11%
Elderly Patients
11%
Nucleus Basalis
11%
Human Brain
11%
Neuritic Plaques
11%
Protein Expression
10%
Anterior Cingulate Cortex
10%
Clinical Dementia Rating
10%
Hippocampus
9%
Frontal Cortex
9%
N-methyl-D-aspartate Receptor (NMDAR)
9%
Alzheimer
9%
Postmortem Brain
8%
Genome-wide Association Study
8%
MRNA Expression
8%
Cortex
7%
Alzheimer's Disease Brain
7%
Myelin
7%
Amyloid Precursor Protein
7%
Receptor Subunits
7%
Cognitive Impairment
7%
Superior Temporal Gyrus
7%
Dementia Severity
6%
Illness
6%
AMPA Receptor (AMPAR)
6%
Cerebral Cortex
5%
Pathophysiology of Schizophrenia
5%
Choline Acetyltransferase (ChAT)
5%
Genetic Risk
5%
Brain Tissue
5%
Cognitive Decline
5%
APOE4
5%
Dysregulation
5%
Postmortem Tissue
5%
Physostigmine
5%
Glutamate
5%
Bipolar Disorder
5%
Neuroscience
Alzheimer's Disease
88%
Gene Expression
29%
Messenger RNA
20%
Oligodendrocyte
18%
Cholinergic
15%
Prefrontal Cortex
14%
Senile Plaque
12%
Clinical Dementia Rating
12%
Hippocampus
12%
Cognitive Disorders
11%
Dorsolateral Prefrontal Cortex
11%
Protein Expression
11%
Glutamic Acid
10%
Receptor
10%
Frontal Lobe
10%
Thalamus
10%
Receptor Subunit
9%
Nucleus Basalis of Meynert
9%
Anterior Cingulate Cortex
9%
Amyloid Precursor Protein
8%
Amyloid Protein
8%
Myelin
7%
Transcriptomics
7%
Synaptic Transmission
6%
Schizophrenia
6%
Cerebral Cortex
6%
Glutamate Receptor
6%
Genome-Wide Association Study
6%
AMPA Receptor
6%
Superior Temporal Gyrus
6%
Choline Acetyltransferase
5%
NMDA Receptor
5%
Cell Signaling
5%
Temporal Lobe
5%
Bipolar Disorder
5%
Tauopathy
5%
Microarrays
5%
Receptor Expression
5%